Targeting of the proteasome worsens atherosclerosis?

Circ Res. 2008 Feb 15;102(3):e37. doi: 10.1161/CIRCRESAHA.107.168963.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Boronic Acids / pharmacology*
  • Bradykinin / pharmacology
  • Cholesterol, Dietary / pharmacology
  • Coronary Artery Disease / enzymology*
  • Coronary Artery Disease / pathology
  • Coronary Circulation / drug effects
  • Dipeptides / pharmacology*
  • Enzyme Activation / drug effects
  • Female
  • Heart Rate / drug effects
  • Hypercholesterolemia / enzymology
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Nitroprusside / pharmacology
  • Oxidative Stress / drug effects
  • Proteasome Endopeptidase Complex / metabolism*
  • Proteasome Inhibitors*
  • Swine
  • Ubiquitin / metabolism
  • Vasodilation / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Boronic Acids
  • Cholesterol, Dietary
  • Dipeptides
  • N-(4-morpholine)carbonyl-beta-(1-naphthyl)-alanyl-leucine boronic acid
  • Proteasome Inhibitors
  • Ubiquitin
  • Vasodilator Agents
  • Nitroprusside
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Proteasome Endopeptidase Complex
  • Bradykinin